EVER

Current Thesis

EverQuote is the online auto/home insurance lead-gen marketplace. The trade that worked in 2024–early-2025 was the carrier ad-spend recovery supercycle: after insurers slashed acquisition budgets in 2022–23 over loss-ratio pain, they came roaring back, driving auto-vertical revenue +97% YoY (Q1'25) and the stock from single digits to a $30.03 high. That narrative is now MATURING into SATURATED. The deceleration is unambiguous: total revenue grew +83% (Q1'25) → +34% (Q2'25) → +20% (Q3'25) → +32% (Q4'25) → +15% in Q1'26 ($190.9M, reported ~early May 2026). Sequentially revenue has plateaued in a $190–195M band for three straight quarters (Q4'25 $195.3M → Q1'26 $190.9M → Q2'26 guide midpoint ~$190M). The stock round-tripped $30 → $16.63 (52-wk low) and has bounced to ~$19.40–19.95 (Jun 2–4 2026), sitting above the 50-DMA ($17.12) but still below the 200-DMA ($22.49). For a narrative-momentum book this is a watch-only name: no accelerating leg in the tape, no catalyst inside 30 days. Not the setup this playbook exists to catch.

Bull Case

• Q1'26 beat + record profitability: revenue $190.9M (+15%) vs guide $175–185M; net income $18.7M; record adjusted EBITDA $29.3M (+30% YoY) — a profitable, cash-generative marketplace, not a cash-burner (8-K, ~May 2026).
• Home/renters is the new emergent growth leg: Q1'26 home revenue $18.5M (+33%); FY'25 $62.7M (+20%). Management explicitly targets growing home from ~10% of revenue toward its ~50% TAM potential and says it will eventually grow faster than auto — a fresh narrative if it inflects.
• Fortress balance sheet + buyback: $178.5M cash, zero debt, $60M revolver undrawn; repurchased 1,068,016 Class-A shares for $19.9M in Q1'26 — shrinking the float into the bounce.
• Sell-side still constructive: consensus Buy, avg PT $25.83 (range $23–$30); JPMorgan's Cory Carpenter raised PT to $24 (Overweight) — implies ~30% upside from ~$19.40.
• Easier YoY comp into Q2: Q2'26 guide $185–195M is ~+21% YoY at midpoint because Q2'25 ($156.6M) was the soft quarter — optically re-accelerating growth headline.

Bear Case

• The narrative already happened. YoY growth collapsed from +83% (Q1'25) to +15% (Q1'26); VMD growth fell from +52% (Q1'25, $46.9M) to +14% (Q3'25, $50.1M). The cyclical ad-spend snapback is largely priced and spent.
• Sequential revenue has stalled around $190M for three quarters; Q1'26 ($190.9M) was actually down sequentially vs Q4'25 ($195.3M). Q2'26 midpoint ~flat. A plateau, not a ramp.
• Broken long-term structure: price is below the 200-DMA ($22.49) — the round-trip from [entry redacted] to $16.63 means anyone who bought the 2024–25 mania is underwater; overhead supply on every rally toward $22–25.
• Analyst PTs were cut from ~$34 to ~$23.83 on cautious carrier-spend commentary — the bullish targets are lower than they were.
• No catalyst in the next 30 days. Q2'26 print lands ~early August (est. ~2026-08-04), outside the window — nothing to drive a momentum move now. Thin tape (avg vol ~328K/day) makes it a low-conviction, hard-to-scale name.

Setup & Price Structure

• Last ~$19.40–19.95 (Jun 2–4 2026). 52-wk range $16.63–$30.03 — mid-range, leaning low.
• 50-DMA $17.12 (above) / 200-DMA $22.49 (below). Classic post-deceleration value-trap-with-a-bounce: reclaimed the 50-DMA off the $16.63 low but capped under the 200-DMA.
• The actionable momentum trigger is NOT here yet: a high-volume reclaim-and-hold of the 200-DMA $22.49 on a home-vertical re-acceleration story would be the first real long setup; absent that, rallies into $22–25 are sells/fades into overhead supply.
• No retail-squeeze dynamic (thin float-turnover, low volume) — do not treat as archetype-6.

Catalyst Calendar (next 30 days)

• None inside 30 days. Q1'26 already printed ~early May 2026 (the binary has passed).
• Q2'26 earnings: est. ~2026-08-04 (outside window) — watch VMD vs the $55–57M guide and home-vertical YoY as the next narrative tell.
• No FDA/PDUFA, no analyst-day, no index event identified for Jun 2026. Monitor for carrier-spend datapoints from peers (Progressive/GEICO/Allstate ad-budget commentary) as orthogonal reads.

What Would Change Our Mind

• Bullish flip → probe long: high-volume daily/weekly close back above the 200-DMA ($22.49), ideally driven by home/renters revenue inflecting to grow faster than auto (next read Q2 ~Aug), plus carrier ad-spend re-acceleration commentary. That converts a dead cyclical into a fresh emergent leg.
• Bearish confirmation → stay out / fade: daily close back below the 50-DMA (~$17.10) = the bounce failed, structure reverts to base; or Q2 VMD guide below the $55M low-end signaling carrier-spend rollover.

Correlation Notes

• Levered to P&C auto-insurance carrier marketing budgets — moves with the insurance pricing/loss-ratio cycle, not with AI or rates directly. Read-throughs from Progressive (PGR), Allstate (ALL), GEICO/Berkshire ad-spend commentary and peer MediaAlpha (MAX), which trades on the same carrier-spend cycle and is the cleanest cluster confirmation/divergence signal.
• Low correlation to the AI/semis complex; this is an idiosyncratic insurtech-marketplace cyclical. Secondary, unpriced optionality from AI-driven lead matching ("SmartCampaigns"), but it is not the price driver today.

[recent archive context: prior dossier had this seeded 2026-05-06 under the incorrect "consumer-discretionary-rotation" theme; corrected here to insurtech-marketplace / auto-insurance ad-spend cycle.]